EN DE
Watch Twareat Medical Care Company for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Twareat Medical Care Company (9627) fair value: what the stock is really worth

As of Nov 5, 2026: fair value (intrinsic value) of Twareat Medical Care Company stock SAR 7.24, price SAR 9.00, that is 19.6% below the price, quality 43 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare SA

TM Twareat Medical Care Company logo Thin data Nov 10, 2026

Twareat Medical Care Company

9627 · SR
Weak valuation

Our calculation puts a fair price 20% below what the stock costs today.

Low debt
Last quarter vs. a year ago: revenue +65%, profit +136%.
Quality 43/100
Expensive Growth (revenue 3y +7.0 %/yr in SAR)
Mixed vs. peers (5/12)
Fair value 7.24 SAR · Overvalued
Loss-making · -1.1% net margin (TTM)
Negative free cash flow
Narrow moat 21/100 · thin data
Thin data
Estimate
Watch Twareat Medical Care Company for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

14.20 SAR 7.40 SAR Fair Value 7.24 SAR Dec 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

11‑month range 7.40 SAR – 14.20 SAR · fair‑value band 5.43 SAR – 9.05 SAR · the 9.00 SAR price screens above the 7.24 SAR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Twareat Medical Care in your weekly email

Every Wednesday you see whether Twareat Medical Care is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Twareat Medical Care Company provides medical care services in remote and industrial areas in the Kingdom of Saudi Arabia. It offers home care; medical evacuation and transportation; medical support; occupational, industrial, and remote area clinics services.

Show moreShow less

The Group is engaged in general construction of residential buildings, renovation of residential and non-residential; buildings, stores of medical devices and products, hospitals, medical operations of hospitals, general medical; complexes, medical operations of medical complexes and one-day surgery centers, ambulance service centers, medical laboratories, home medical service centers, medical clinic mobile, telemedicine and telemedicine centers, medical operations of medical laboratories, radiology centers and supporting medical services, activities of drug stores, retail sale of medical devices, equipment and supplies, repair and maintenance of medical equipment and transformation of vehicles to medical equipment.

Twareat Medical Care Company was founded in 2010 and is based in Al Khobar, the Kingdom of Saudi Arabia.

Stock analysis

Twareat Medical Care Company (9627) currently trades at 9.00 SAR, while our estimate is 7.24 SAR, 20% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: 5.43 SAR (bear) to 9.05 SAR (bull), the price of 9.00 SAR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Twareat Medical Care Company reported revenue of 183M SAR in FY2025 versus 150M SAR in FY2022, a compound +7.0%/yr. Reported net income was −10.3M SAR in FY2025.

Key figures

Market cap 360M SAR (≈ $95.9M) Micro · P/S ratio 1.32 · EPS (TTM) −0.0700 SAR · Dividend yield 3.1% · Net margin −1.1% · Return on equity −4.3% · Return on assets (EBIT) 16.7% (4-year average) · Operating margin 10.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 21 out of 100 (low confidence).

What moves the price

The share trades about 37% below its 52-week high and 22% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −20%, 9627 screens richer than that median.

Fair Value

Bear 5.43 SAR Fair Value 7.24 SAR Bull 9.05 SAR
Price 9.00 SAR · Downside -19.6%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 43/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 35
How much profit the company makes from its sales and capital
Quality Growth 16
Are margins and returns getting better?
Cashflow 10
Do the profits arrive as real cash?
Financial strength 60
Debt, balance sheet and risk of trouble
Investment 70
Does it invest with discipline instead of growing at any price?
Low Volatility 17
How calm the share price moves, does not count
Price momentum 27
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 12
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 22/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−4.5%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
18.0% (2022) → −3.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

9627 screens overvalued: fair value 20% below the price. Compare with HCA Healthcare, Inc →

Compare Twareat Medical Care Company with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 246 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 43 · Bottom 25%
Fair Value upside −19.6% · Below median
Profitability
Return on assets −9.6% · Bottom 25%
Net margin (12 months) −1.1% · Bottom 25%
Operating margin (12 months) 10.7% · Above median
Growth and dividend
Revenue growth (quarter YoY) 65.1% · Top 25%
Dividend yield (12 months) 3.1% · Above median
Balance sheet
Debt / equity 0.07× · Below median

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/B 7.72× · Priciest 25%
P/S (12 months) 1.49× · Cheaper than median
EV/EBITDA 53.8× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)7 · sector 33
FUTURE (revenue growth)100 · sector 33
PAST (return on equity)0 · sector 31
HEALTH (low debt)96 · sector 90
DIVIDEND (yield)62 · sector 39

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Fresenius Medical Care AG FMS $22.74 $46.55 +105% vs 9627
Aier Eye Hospital Group 300015 ¥8.85 ¥10.88 +23% vs 9627
DaVita Inc DVA $179.28 $218.90 +22% vs 9627
HCA Healthcare, Inc HCA $504.42 $547.34 +9% vs 9627
Tenet Healthcare Corporation THC $290.27 $279.20 −4% vs 9627
The Ensign Group ENSG $185.09 $140.09 −24% vs 9627
Encompass Health Corporation EHC $142.51 $94.81 −33% vs 9627
Fresenius SE FRE €53.47 €34.77 −35% vs 9627
Apollo Hospitals Enterprise Limited APOLLOHOSP ₹8,550 ₹5,234 −39% vs 9627
Dr. Sulaiman Al Habib Medical Services Group 4013 214.70 SAR 109.45 SAR −49% vs 9627

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Twareat Medical Care Company: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Twareat Medical Care Company Fair Value". https://www.fairvalue-calculator.com/stock/9627

Frequently asked questions

Is Twareat Medical Care Company (9627) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is 7.24 SAR versus a price of 9.00 SAR, about 20% lower (overvalued).
What is the fair value of 9627?
Our estimate for Twareat Medical Care Company is 7.24 SAR (as of Nov 10, 2026), built from audited fundamentals. The current price: 9.00 SAR.
What is the quality score of 9627?
Twareat Medical Care Company has a Quality Score of 43/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Twareat Medical Care Company (9627)?
Our calculated price target is the estimate of 7.24 SAR (as of Nov 10, 2026). Cautious scenario 5.43 SAR, optimistic scenario 9.05 SAR. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Twareat Medical Care Company stock forecast for 2026?
Our estimate puts fair value at 7.24 SAR, about 20% lower versus a price of 9.00 SAR (overvalued). Cautious scenario 5.43 SAR, optimistic scenario 9.05 SAR. The calculation is refreshed regularly with new filings.
What is the revenue of Twareat Medical Care Company (9627)?
Twareat Medical Care Company reported trailing-twelve-month revenue of about 242M SAR (latest available figure, as of Nov 10, 2026).
Does Twareat Medical Care Company pay a dividend?
Twareat Medical Care Company currently shows a dividend yield of 3.12% relative to its recent price (as of Nov 10, 2026).
How much is the dividend of Twareat Medical Care Company (9627)?
Twareat Medical Care Company has a dividend yield of 3.1%.
What is the intrinsic value of Twareat Medical Care Company (9627)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Twareat Medical Care Company it is 7.24 SAR per share (as of Nov 10, 2026), against a price of 9.00 SAR.
Is Twareat Medical Care Company stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 9627 trades above its calculated fair value: price 9.00 SAR, fair value 7.24 SAR, a gap of about −20% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 9627?
No. The price is what the market pays today (9.00 SAR); the fair value is what the company's own numbers justify (7.24 SAR). For Twareat Medical Care Company the two are 1.76 SAR per share apart. That gap is exactly why we show both numbers side by side.
How much is Twareat Medical Care Company worth?
The market values Twareat Medical Care Company at about 360M SAR (market capitalisation, as of Nov 10, 2026). Per share that is 9.00 SAR; our models calculate a fair value of 7.24 SAR per share.
What do the bullish and bearish scenarios say about 9627?
Our models span a range for Twareat Medical Care Company: cautious scenario 5.43 SAR, base 7.24 SAR, optimistic 9.05 SAR per share (as of Nov 10, 2026, price 9.00 SAR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Twareat Medical Care Company (9627)?
Balance-sheet figures for Twareat Medical Care Company (as of Nov 10, 2026): return on equity −4.3%, debt of 0.07 per unit of equity. They feed the Quality Score of 43/100, which measures business quality independently of the share price.
How far is 9627 from its 52-week high?
Twareat Medical Care Company trades at 9.00 SAR, about 37% below its 52-week high of 14.20 SAR and 22% above the low of 7.40 SAR (as of Nov 5, 2026). Distance from the high says nothing about value: that is what the fair value of 7.24 SAR is for.
Which stocks are comparable to Twareat Medical Care Company?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Twareat Medical Care Company stock attractive at the current price?
The data as of Nov 10, 2026: price 9.00 SAR, calculated fair value 7.24 SAR (−20%), Quality Score 43/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Twareat Medical Care Company itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Twareat Medical Care Company (9627)?
The closing price on Nov 5, 2026 was 9.00 SAR. Our estimate is 7.24 SAR, about 20% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Twareat Medical Care Company right now?
Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Twareat Medical Care Company

How large is the market capitalisation of Twareat Medical Care Company (9627)?
The market capitalisation of Twareat Medical Care Company is 360M SAR (≈ $95.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Twareat Medical Care Company (9627)?
The price-to-sales ratio of Twareat Medical Care Company is 1.32 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Twareat Medical Care Company (9627)?
Earnings per share at Twareat Medical Care Company are −0.0700 SAR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Twareat Medical Care Company (9627)?
The dividend yield of Twareat Medical Care Company is 3.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Twareat Medical Care Company (9627)?
The net margin of Twareat Medical Care Company is −1.1% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Twareat Medical Care Company (9627)?
The return on equity (ROE) of Twareat Medical Care Company is −4.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Twareat Medical Care Company (9627)?
On an EBIT basis the return on assets of Twareat Medical Care Company is 16.7% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Twareat Medical Care Company (9627)?
The operating margin of Twareat Medical Care Company is 10.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Twareat Medical Care Company (9627)?
Revenue at Twareat Medical Care Company is growing +65.1% versus a year earlier (3y avg +7.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Twareat Medical Care Company (9627)?
Earnings per share at Twareat Medical Care Company are growing +136% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Twareat Medical Care Company (9627) generate?
The free cash flow of Twareat Medical Care Company is −6.7M SAR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Twareat Medical Care Company (9627) carry?
The net debt of Twareat Medical Care Company is 26.9M SAR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Twareat Medical Care Company in the live analysis

One click puts Twareat Medical Care Company on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.